Volume 4, Issue 5: P. aeruginosa Eradication
e-Cystic Fibrosis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with Cystic Fibrosis. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.
(Volume 4, Issue 5)
Nurses and health care professionals involved in the care of patients with Cystic Fibrosis.
After participating in this activity, the participant will demonstrate the ability to:
- Distinguish between existing, newly available, and investigational inhaled antibiotics for treating chronic pulmonary infections.
- Identify appropriate use and selection of inhaled therapies in combination.
- Evaluate current evidence describing the use of intermittent, continuous, cycled inhaled antibiotics therapies to suppress airway infections.
- Recognize and apply best practices in managing pulmonary exacerbations.
- Incorporate evidence-based strategies and newly available technologies to improve patient adherence to inhaled medication.
Margaret Rosenfeld, MD, MPH
Division of Pulmonary Medicine
Seattle Children’s Hospital and Department of Pediatrics
University of Washington School of Medicine
- 1.00 ANCC